Scientists now have a slew of biomarkers, both fluid assays and PET ligands, that distinguish Alzheimer’s from other neurodegenerative diseases, such as frontotemporal dementia, Parkinson’s, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback